Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: Baseline characteristics, previous therapies, and transition periods of the first 2,000 subjects in the PROSPECT study

doi:10.1016/j.jaad.2018.05.1021

Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: Baseline characteristics, previous therapies, and transition periods of the first 2,000 subjects in the PROSPECT study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.1021 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB257

Keyword(s):

Plaque Psoriasis ◽

Clinical Care ◽

Severe Plaque Psoriasis ◽

Routine Clinical Care ◽

Baseline Characteristics

Download Full-text

Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.14604 ◽

2017 ◽

Vol 32 (3) ◽

pp. 411-419 ◽

Cited By ~ 9

Author(s):

A. Körber ◽

D. Thaçi ◽

R. von Kiedrowski ◽

T. Bachhuber ◽

N. Melzer ◽

...

Keyword(s):

Plaque Psoriasis ◽

Clinical Care ◽

Real Life ◽

Severe Plaque Psoriasis ◽

Life Data ◽

Routine Clinical Care ◽

Real Life Data

Download Full-text

14190 Treatment with secukinumab of severe plaque psoriasis in pediatric patients: Study design and baseline characteristics of a double-blind study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2020.06.620 ◽

2020 ◽

Vol 83 (6) ◽

pp. AB133

Author(s):

Andrzej Kaszuba ◽

Philemon Papanastasiou ◽

Deborah Keefe ◽

Manmath Patekar ◽

Lixin Zhang ◽

...

Keyword(s):

Study Design ◽

Plaque Psoriasis ◽

Pediatric Patients ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Severe Plaque Psoriasis ◽

Baseline Characteristics

Download Full-text

Correct performance of subcutaneous injections in plaque psoriasis: comparison of trained and untrained patients with different application systems in routine clinical care

Journal of Dermatological Treatment ◽

10.1080/09546634.2020.1720580 ◽

2020 ◽

pp. 1-9

Author(s):

Franziska Stenger ◽

Anke König ◽

Falk Ochsendorf ◽

Roland Kaufmann ◽

Andreas Pinter

Keyword(s):

Plaque Psoriasis ◽

Clinical Care ◽

Subcutaneous Injections ◽

Routine Clinical Care ◽

Correct Performance ◽

Application Systems

Download Full-text

Sociodemographic and baseline disease profile of patients with moderate to severe chronic plaque psoriasis treated with secukinumab vs. other treatments in Canadian routine clinical care: Results from the PURE registry

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2018.05.1048 ◽

2018 ◽

Vol 79 (3) ◽

pp. AB265

Keyword(s):

Plaque Psoriasis ◽

Clinical Care ◽

Chronic Plaque Psoriasis ◽

Routine Clinical Care

Download Full-text

The TRIUMPH cohort study: Initiation of Triumeq® (DTG/ABC/3TC) in routine clinical care in germany – a comparison to baseline characteristics of the DOL-ART cohort

10.26226/morressier.572768e5d462b8029237f320 ◽

2016 ◽

Author(s):

Nils Postel

Keyword(s):

Cohort Study ◽

Clinical Care ◽

Routine Clinical Care ◽

Baseline Characteristics

Download Full-text

Bimekizumab provides rapid and sustained improvements in scalp and nail outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized, double blinded, Phase 2b extension study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.34 ◽

2019 ◽

Vol 3 ◽

pp. S34

Author(s):

Andrew Blauvelt ◽

Kim A Papp ◽

Joseph F Merola ◽

Alice B Gottlieb ◽

Nancy Cross ◽

...

Keyword(s):

Plaque Psoriasis ◽

Extension Study ◽

Severe Plaque Psoriasis ◽

Double Blinded

Abstract not available.

Download Full-text

Evaluation of the PGAxBSA Composite Tool in Patients with Moderate-to-Severe Plaque Psoriasis

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.13 ◽

2017 ◽

Vol 1 ◽

pp. s14

Author(s):

Kristina Callis Duffin ◽

J Mark Jackson ◽

Joana Goncalves ◽

Eugenia Levi ◽

Jerry Bagel

Keyword(s):

Plaque Psoriasis ◽

Severe Plaque Psoriasis ◽

Composite Tool

Abstract Not Available Disclosure: Study supported by Celgene.

Download Full-text

Comparison of Ixekizumab and Ustekinumab Efficacy in the Treatment of Nail Lesions of Patients With Moderate-to-Severe Plaque Psoriasis: 52-Week Data From the IXORA-S Trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.2.supp.106 ◽

2018 ◽

Vol 2 ◽

pp. S117

Author(s):

Norman Wasel ◽

Yves Dutronc ◽

Birgit Schinzel ◽

Jean-Philippe Lacour

Keyword(s):

Plaque Psoriasis ◽

Severe Plaque Psoriasis

Download Full-text

Anti–Saccharomyces cerevisiae antibodies (ASCA) are biomarkers of moderate-to-severe hidradenitis suppurativa (HS), but not of severe plaque psoriasis: Results from a prospective, multicenter study

10.26226/morressier.595a9c57d462b80296c9f714 ◽

2017 ◽

Author(s):

Jeremy Gottlieb

Keyword(s):

Saccharomyces Cerevisiae ◽

Multicenter Study ◽

Plaque Psoriasis ◽

Hidradenitis Suppurativa ◽

Prospective Multicenter Study ◽

Severe Plaque Psoriasis

Download Full-text

Pharmacological treatment for borderline personality disorder: comparing data from routine clinical care with recommended guidelines

10.26226/morressier.59d4913bd462b8029238a351 ◽

2017 ◽

Author(s):

Friedrich Riffer

Keyword(s):

Borderline Personality Disorder ◽

Personality Disorder ◽

Pharmacological Treatment ◽

Clinical Care ◽

Borderline Personality ◽

Routine Clinical Care ◽

Recommended Guidelines

Download Full-text